Melden Sie sich an, um zu speichern und Updates zu erhalten.
Bewusstseinsverändernde Substanzen schneiden (immer noch) in klinischen Studien schlecht ab
This week I want to look at where we are with psychedelics, the mind-altering substances that have somehow made the leap from counterculture to major focus of clinical research. Compounds like psilocybin—which is found in magic mushrooms—are being explored for all sorts of health applications, including treatments for depression, PTSD, addiction, and even obesity. Over…
Quellartikel
MIT Technology Review (United States) | Mar 20, 2026
Your votes count
No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.
KI-übersetzt · Original anzeigen
Psychedelics like psilocybin offer groundbreaking potential for treating mental health disorders, providing hope where traditional therapies have failed.
KI-übersetzt · Original anzeigen
Relying on mind-altering substances for mental health treatment risks over-medication and neglecting holistic approaches like therapy and lifestyle changes.
KI-übersetzt · Original anzeigen
Psychedelics could revolutionize addiction treatment, offering unique mechanisms that could help individuals break free from cycles of substance abuse.
KI-übersetzt · Original anzeigen
The clinical trial results for psychedelics are mixed, indicating that while some patients benefit, many others do not, necessitating careful consideration before widespread use.
KI-übersetzt · Original anzeigen
The hype around psychedelics in clinical trials may overshadow the need for rigorous scientific evaluation, potentially leading to premature acceptance in healthcare.
💡 How This Works
- • Add Statements: Post claims or questions (10-500 characters)
- • Vote: Agree, Disagree, or Unsure on each statement
- • Respond: Add detailed pro/con responses with evidence
- • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement
Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.
Support us